189 related articles for article (PubMed ID: 27626693)
1. Constructing Bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progression.
Gong Y; Wang L; Chippada-Venkata U; Dai X; Oh WK; Zhu J
Oncotarget; 2016 Oct; 7(42):68688-68707. PubMed ID: 27626693
[TBL] [Abstract][Full Text] [Related]
2. Identification of transcription factor co-regulators that drive prostate cancer progression.
Siddappa M; Wani SA; Long MD; Leach DA; Mathé EA; Bevan CL; Campbell MJ
Sci Rep; 2020 Nov; 10(1):20332. PubMed ID: 33230156
[TBL] [Abstract][Full Text] [Related]
3. In-Silico Integration Approach to Identify a Key miRNA Regulating a Gene Network in Aggressive Prostate Cancer.
Cava C; Bertoli G; Colaprico A; Bontempi G; Mauri G; Castiglioni I
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562723
[TBL] [Abstract][Full Text] [Related]
4. A Network Biology Approach Identifies Molecular Cross-Talk between Normal Prostate Epithelial and Prostate Carcinoma Cells.
Trevino V; Cassese A; Nagy Z; Zhuang X; Herbert J; Antczak P; Clarke K; Davies N; Rahman A; Campbell MJ; Guindani M; Bicknell R; Vannucci M; Falciani F
PLoS Comput Biol; 2016 Apr; 12(4):e1004884. PubMed ID: 27124473
[TBL] [Abstract][Full Text] [Related]
5. Y chromosome gene copy number and lack of autism phenotype in a male with an isodicentric Y chromosome and absent NLGN4Y expression.
Ross JL; Bloy L; Roberts TPL; Miller J; Xing C; Silverman LA; Zinn AR
Am J Med Genet B Neuropsychiatr Genet; 2019 Oct; 180(7):471-482. PubMed ID: 31161682
[TBL] [Abstract][Full Text] [Related]
6. Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency.
Yeh HY; Cheng SW; Lin YC; Yeh CY; Lin SF; Soo VW
BMC Med Genomics; 2009 Dec; 2():70. PubMed ID: 20025723
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
[TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of prostate cancer aggressiveness.
Feik E; Schweifer N; Baierl A; Sommergruber W; Haslinger C; Hofer P; Maj-Hes A; Madersbacher S; Gsur A
Prostate; 2013 Sep; 73(13):1413-26. PubMed ID: 23813660
[TBL] [Abstract][Full Text] [Related]
9. Interrogation of ERG gene rearrangements in prostate cancer identifies a prognostic 10-gene signature with relevant implication to patients' clinical outcome.
Bismar TA; Alshalalfa M; Petersen LF; Teng LH; Gerke T; Bakkar A; Al-Mami A; Liu S; Dolph M; Mucci LA; Alhajj R
BJU Int; 2014 Feb; 113(2):309-19. PubMed ID: 24006850
[TBL] [Abstract][Full Text] [Related]
10. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
[TBL] [Abstract][Full Text] [Related]
11. EphA3, induced by PC-1/PrLZ, contributes to the malignant progression of prostate cancer.
Wu R; Wang H; Wang J; Wang P; Huang F; Xie B; Zhao Y; Li S; Zhou J
Oncol Rep; 2014 Dec; 32(6):2657-65. PubMed ID: 25231727
[TBL] [Abstract][Full Text] [Related]
12. Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines.
Trojan L; Schaaf A; Steidler A; Haak M; Thalmann G; Knoll T; Gretz N; Alken P; Michel MS
Anticancer Res; 2005; 25(1A):183-91. PubMed ID: 15816537
[TBL] [Abstract][Full Text] [Related]
13. Significance of the TMPRSS2:ERG gene fusion in prostate cancer.
Wang Z; Wang Y; Zhang J; Hu Q; Zhi F; Zhang S; Mao D; Zhang Y; Liang H
Mol Med Rep; 2017 Oct; 16(4):5450-5458. PubMed ID: 28849022
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide copy number analysis reveals candidate gene loci that confer susceptibility to high-grade prostate cancer.
Poniah P; Mohd Zain S; Abdul Razack AH; Kuppusamy S; Karuppayah S; Sian Eng H; Mohamed Z
Urol Oncol; 2017 Sep; 35(9):545.e1-545.e11. PubMed ID: 28527622
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.
Nishikawa R; Goto Y; Kurozumi A; Matsushita R; Enokida H; Kojima S; Naya Y; Nakagawa M; Ichikawa T; Seki N
Int J Urol; 2015 Sep; 22(9):867-77. PubMed ID: 26059417
[TBL] [Abstract][Full Text] [Related]
16. Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation.
Doldi V; Callari M; Giannoni E; D'Aiuto F; Maffezzini M; Valdagni R; Chiarugi P; Gandellini P; Zaffaroni N
Oncotarget; 2015 Oct; 6(31):31441-60. PubMed ID: 26375444
[TBL] [Abstract][Full Text] [Related]
17. A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancer.
Seibert JK; Quagliata L; Quintavalle C; Hammond TG; Terracciano L; Odermatt A
Cancer Med; 2015 Nov; 4(11):1717-29. PubMed ID: 26311046
[TBL] [Abstract][Full Text] [Related]
18. High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
Xie JJ; Zhuo YJ; Zheng Y; Mo RJ; Liu ZZ; Li BW; Cai ZD; Zhu XJ; Liang YX; He HC; Zhong WD
Int Urol Nephrol; 2017 May; 49(5):817-823. PubMed ID: 28213802
[TBL] [Abstract][Full Text] [Related]
19. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
[TBL] [Abstract][Full Text] [Related]
20. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
Xiang J; Bian C; Wang H; Huang S; Wu D
J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
